Skip to content

NAVIDEA BIOPHARMACEUTICALS, INC.

Delisted

CIK 810509fmd_0QXF3FW726K0BVVWRQQH6VG8S8Manufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard

Coverage: Jan 01, 2009 to Sep 30, 2023, 55 periods

Ratios computed from the standardized statements. Select a value to open its proof.

Loading
FinancialMD terminal